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Purpose: This study was aimed to replicate previously GWAS-identified sprint-related 41 
polymorphisms in three different cohorts of top-level sprinters and to further validate obtained 42 
results in functional studies. Methods: A total of 240 Japanese, 290 Russians and 593 43 
Brazilians were evaluated in a case–control approach. Of these, 267 were top-level 44 
sprint/power athletes. In addition, the relationship between selected polymorphisms and 45 
muscle fiber composition was evaluated in 211 Japanese and 287 Finnish individuals. 46 
Results: The G-allele of the rs3213537 polymorphism was overrepresented in Japanese (OR: 47 
2.07, P = 0.024) and Russian (OR: 1.93, P = 0.027) sprinters compared to endurance athletes 48 
and associated with increased proportion of fast-twitch muscle fibers in Japanese (P = 0.02) 49 
and Finnish (P = 0.041) individuals. Meta-analysis of data from the four cohorts confirmed 50 
that the presence of the G/G genotype rather than G/A+A/A genotypes increased the odds 51 
ratio of being a sprinter compared to controls (OR: 1.54, P = 0.005), endurance athletes (OR: 52 
1.79, P = 0.001) or controls + endurance athletes (OR: 1.61, P = 0.001). Furthermore, male 53 
sprinters with the G/G genotype were found to have significantly faster personal times in the 54 
100-m dash than those with G/A+A/A genotypes (10.50 ± 0.26 vs. 10.76 ± 0.31, P = 0.014). 55 
Conclusion: The rs3213537 polymorphism found in the CPNE5 gene was identified as a 56 
highly replicable variant associated with sprinting ability and increased proportion of fast-57 
twitch muscle fibers, in which the homozygous genotype for the major allele (i.e., the G/G 58 
genotype) is preferable for performance. 59 
 60 
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The sprint ability is a core capacity that underlies performance in many individual sports as 64 
well as team sports. Naturally, pure sprint athletes (e.g., 100-m runners) perform better on 65 
physiological and mechanical variables of sprint performance 1. A velocity-oriented force–66 
velocity profile is a major contributing factor for a better sprint performance 2. The maximal 67 
sprint velocity and mean power produced over the event distance strongly influence 68 
performance 3. During a sprint task, power output demand increases exponentially with 69 
velocity and the best sprinters accelerate over a longer distance than their lower performing 70 
counterparts 4. 71 
 Sports performance is the combined result of numerous intrinsic and extrinsic factors, 72 
that is, the interaction between genetic factors and the environmental stimulus. Although 73 
training and other environmental stimulus are critical to performance achievement, individual 74 
performance thresholds can be determined by our genetic make-up. Twin studies have 75 
reported moderate to high heritability estimates for maximum movement speed as well as for 76 
other sprint and power phenotypes 5, 6 and so it has been proposed that elite sprint 77 
performance strongly depends on genetic characteristics. 78 
 Like other sports phenotypes, the sprint ability is a complex and polygenic 79 
phenomenon guided by the interaction of multiple genes and most likely gene variants. There 80 
are several polymorphisms that have been associated with elite power and sprint athletic 81 
status 7. In particular, some of them were also associated with faster sprint times 8, 9; however, 82 
many of the polymorphisms suggested as favorable to sprinters were evaluated using case–83 
control approaches that have not yet been replicated in subsequent studies or independent 84 
samples 7. Replication studies are of paramount importance to better evaluate and characterize 85 
performance-relevant polymorphisms. The same association in independent samples indicates 86 
a greater relevance between the polymorphism and the target phenotype. 87 
 Recently, Pickering et al. 10 first performed a genome-wide association study (GWAS) 88 
to identify sprint-related genetic variants. These authors exposed a set of new polymorphisms 89 
associated with short-distance sprints in youth football players, some of which were replicated 90 
in an independent cohort of Polish women. The replication of these findings in top-level 91 
athletes of different ethnicities would be interesting, since only one cohort of Russian athletes 92 
validated the most associated polymorphisms.  93 
 Therefore, the purpose of this study was to replicate GWAS-identified sprint-related 94 
polymorphisms in three different cohorts of top-level sprinters. A secondary purpose of this 95 
study was to evaluate the relationship between these polymorphisms and the proportion of 96 
fast-twitch muscle fibers in two different cohorts. First, the selected polymorphisms were 97 
evaluated for sprinter athletic status and proportion of fast-twitch muscle fibers in a Japanese 98 
cohort. Subsequently, the most consistent polymorphism was evaluated for sprinter athletic 99 
status in two other cohorts from Russia and Brazil, and evaluated for proportion of fast-twitch 100 
muscle fibers in Finnish individuals. Since the target phenotype is the sprint ability, sprinters 101 
were compared to non-athletes (controls) or endurance athletes (the metabolic demands 102 
required to perform sprint or endurance events are opposites of each other). 103 
 104 
Methods 105 
Table 1 shows the polymorphisms selected for use in this study. All of them are single 106 
nucleotide polymorphisms (SNPs) and were selected based on a previous study 10 and 107 
according to the following criteria: biallelic polymorphisms located on autosomal 108 
chromosomes, two replications in the initial study and minor allele frequency > 1% in the 109 
Japanese population. Although the rs12688220 and rs8064257 polymorphisms also showed 110 
two replications in the initial study, they were not included because they did not meet the 111 
inclusion criteria. 112 
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 All cohorts included in this study had their procedures conducted according to the 113 
Declaration of Helsinki ethical principles for research involving human subjects. The 114 
Japanese studies were approved by the ethics committee of the Juntendo University and 115 
Fukuoka University. The Finnish study was approved by the coordinating ethics committee of 116 
the Hospital District of Helsinki and Uusimaa (this data was used with permission; Database 117 
of Genotypes and Phenotypes (dbGaP) Study Accession: phs000867.v1.p1). The Russian 118 
study was approved by the ethics committee of the Federal Research and Clinical Center of 119 
Physical-chemical Medicine of the Federal Medical and Biological Agency of Russia. The 120 
Brazilian study was approved by the ethics committee of the School of Physical Education 121 
and Sport, University of Sao Paulo, São Paulo, Brazil. A written informed consent was 122 
obtained from each participant. 123 
 124 
The Japanese Cohort 125 
The Japanese study involved 114 athletes (91 males and 23 females), of which 54 were 126 
sprint/power athletes (100-400 m runners, jumpers and throwers; mean age ± SD: 28 ± 7 127 
years) and 60 endurance runners (800 m to marathon; mean age ± SD: 24 ± 3 years). All of 128 
these athletes were international-level competitors. The control group comprised 126 healthy 129 
Japanese individuals. 130 
 Total DNA was isolated from saliva or venous blood using the Oragene･DNA 131 
Collection Kit (DNA Genotek, Ontario, Canada) or the QIAamp DNA blood Maxi Kit 132 
(QIAGEN, Hilden, Germany), respectively. The total DNA content was measured using the 133 
NanoDrop 8000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). 134 
Subsequently, DNA samples were adjusted to a concentration of 50 ng/μL with Tris-EDTA 135 
buffer and stored at 4°C. Total DNA samples were genotyped using the HumanOmniExpress 136 
Beadchip (Illumina, San Diego, CA, USA) to genotype > 700,000 SNPs, according to the 137 
manufacturer’s instructions. Genotype calls were performed with Illumina GenomeStudio 138 
software and PLINK was used for quality control checks and association analyses. 139 
 140 
Evaluation of skeletal muscle fiber types 141 
First, a cohort of 203 Japanese healthy individuals (98 men and 105 women, with age range 142 
20-79 years) performed muscle biopsy was used for the association study between sprint-143 
related polymorphisms and muscle fiber composition. Muscle samples were obtained from the 144 
belly of the vastus lateralis and myosin heavy chain (MHC) isoforms were determined by 145 
performing glycerol SDS-PAGE, as previously described 11. These individuals had their DNA 146 
samples isolated from venous blood and the polymorphisms were genotyped using the 147 
Japonica SNP array 12. 148 
 Second, muscle fiber composition in 287 Finnish individuals (167 men, age 59.5 ± 8.1 149 
years; 120 women, age 60.7 ± 7.4 years) from the FUSION study was estimated based on the 150 
expression of the myosin heavy chain 1 (MYH1), myosin heavy chain 2 (MYH2), myosin 151 
heavy chain 7 (MYH7), Ca2+ ATPase A1 and Ca2+ ATPase A2 genes, as previously described 152 
13. Muscle samples were obtained from the vastus lateralis using a conchotome, under local 153 
anesthesia with 20 mg∙ml−1 lidocaine hydrochloride without epinephrine 14. DNA samples 154 
were extracted from the blood and the polymorphisms were genotyped using the 155 
HumanOmni2.5-4v1_H BeadChip array (Illumina, San Diego, CA, USA). 156 
 157 
The Russian Cohort 158 
The Russian study involved 173 athletes (99 males and 74 females; mean age ± SD: 31.3 ± 159 
7.5 years), of which 70 were elite sprinters (100-400 m runners, 500-1000 m speed skaters, 50 160 
m swimmers) and 103 elite endurance athletes (biathletes, rowers, cross-country skiers, 3-10 161 
km runners, 800-1500 m swimmers and triathletes). All of these athletes were international-162 
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level competitors, of which 30 (13 sprinters and 17 endurance athletes) were highly elite 163 
athletes (i.e., prize winners in international competitions). The control group comprised 117 164 
healthy unrelated citizens (66 males and 51 females, mean age ± SD: 47.9 ± 4.8 years), 165 
without any competitive sport experience. This Russian cohort is independent of the one 166 
previously published 10. 167 
 Molecular genetic analysis was performed with DNA samples obtained from 168 
leukocytes (venous blood). Four millilitres of venous blood was collected in tubes containing 169 
EDTA (Vacuette EDTA tubes; Greiner Bio-One, Kremsmünster, Austria). Blood samples 170 
were transported to the laboratory at 4°C, and DNA was extracted on the same day. DNA 171 
extraction and purification were performed using a commercial kit according to the 172 
manufacturer's instructions (Technoclon, Moscow, Russia), which included chemical lysis, 173 
selective DNA binding on silica spin columns and ethanol washing. Extracted DNA quality 174 
was assessed by agarose gel electrophoresis. The genotyping process was performed using 175 
HumanOmni1-Quad BeadChips or HumanOmniExpress BeadChips (Illumina, San Diego, 176 
CA, USA) to genotype > 900,000 SNPs. The assay required 200 ng of DNA sample as input 177 
with a concentration of at least 50 ng/µl. Exact concentrations of DNA in each sample were 178 
measured using a Qubit Fluorometer (Invitrogen, Waltham, MA, USA). All further 179 
procedures were performed according to the instructions of the Infinium High-Density Assay. 180 
 181 
The Brazilian Cohort 182 
The Brazilian study involved 305 athletes (200 males and 105 females; mean age ± SD: 25.4 183 
± 6.9 years), of which 143 were elite sprinters (100-400 m runners, 50-200 m swimmers, 184 
canoeing and cycling) and 162 endurance athletes (rowers, > 1.5 km runners, 400-1500 m 185 
swimmers and triathletes). While 36% of these athletes were nationally prominent 186 
competitors, 64% were international-level competitors. The control group comprised 288 187 
healthy Brazilian individuals (187 males and 101 females, mean age ± SD: 29.6 ± 8.1 years), 188 
without any competitive sport experience. 189 
 Genomic DNA of the Brazilian participants was isolated from buccal epithelial cells 190 
obtained from mouthwashes with a 0.9% saline solution prepared with DNA- and DNAse-191 
free water as previously described 8. Briefly, the DNA samples were extracted using 192 
chloroform, precipitated using ethanol and resuspended with 1× Tris-EDTA buffer. DNA 193 
quantification and quality assessment were performed using the NanoDrop 2000 194 
spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The A260/A280 ratio 195 
was used to evaluate the quality of the sample, which values between 1.7 and 2.1 were 196 
considered acceptable The genotyping process was performed using a pre-designed specific 197 
TaqMan® SNP Genotyping Assay (Applied Biosystems, Foster city, CA, USA), according to 198 
the manufacturer's instructions and using the Rotor-Gene Q PCR cycler (Qiagen, Hilden, 199 
Germany). A scatter plot showing the endpoint fluorescence signals (i.e., an increase in VIC 200 
or FAM fluorescent signal) was used to discriminate the genotypes. The transcript alleles 201 
were used similarly to that previously used. 202 
 203 
Association with sprint performance 204 
To further investigate the influence of sprint-related polymorphisms on sprint performance, a 205 
sample of 37 top-level 100-m runners (28 Brazilians and 9 Russians) had their personal best 206 
sprint running time in the 100-m dash at official events compared between the genotypes of 207 
the selected polymorphism. Athlete’s personal records were acquired using the International 208 
Association of Athletics Federations (IAAF) database, available online at 209 
https://www.worldathletics.org/athletes. Only athletes with performance data available on the 210 




Statistical analysis 213 
First of all, the Chi-square test (2) was used to test for the presence of the Hardy-Weinberg 214 
equilibrium (HWE) in each control group. A departure from HWE was observed when 2 > 215 
3.84 (i.e., P > 0.05). Thereafter, the frequencies of genotypes or alleles were compared 216 
between sprinters and ethnically-matched controls or ethnically-matched endurance athletes 217 
using the 2 test or Fisher’s exact test when appropriate. Differences in the proportion of 218 
muscle fiber types between groups with different genotypes were analyzed using unpaired t-219 
test and one-way ANOVA. The unpaired t-test was also used to evaluate the influence of the 220 
selected polymorphism on 100-m sprint performance. The significance level was established 221 
at P < 0.05. 222 
 For the pooled analysis of the Japanese, Russian and Brazilian cohorts, meta-analysis 223 
was conducted using the Review Manager (RevMan) computer program version 5.3 224 
(Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). Data from 225 
a previously published Russian case-control study 10 were also used in the meta-analysis, that 226 
is, data from 99 Russian highly elite athletes (i.e., Winners of World Championships, World 227 
Cups or Olympic Games; 43 sprinters and 56 endurance athletes) and 173 controls were also 228 
included in the meta-analysis. The DerSimonian and Laird random-effects model was used to 229 
calculate weighted odds ratio (OR) and its 95% confidence interval (95% CI). The test of 230 
overall effect was assessed using the Z score with the significance level established at P < 231 
0.05. Heterogeneity between studies was assessed using the standard 2 test (Cochran Q test) 232 
and the I2 statistic. 233 
 234 
Results 235 
Case–control association study 236 
Of the three polymorphisms evaluated in the Japanese case-control study, only the rs3213537 237 
of the copine 5 (CPNE5) gene was found to be significant. The G-allele of the rs3213537 238 
polymorphism was overrepresented in Japanese sprinters compared to endurance athletes 239 
(80.6 vs. 66.7%; P = 0.024) and associated with increased proportion of glycolytic fast-twitch 240 
(IIx) muscle fibers in Japanese male controls (G/G (n = 69) 24.7 ± 9.4%, G/A (n = 22) 22.1 ± 241 
6.9%, A/A (n = 7) 16.7 ± 7.0%; P = 0.02). A strong trend towards an increase in the 242 
proportion of type IIx fibers was observed in Japanese males even when the analysis was 243 
adjusted for age (P = 0.061). In addition, the G-allele of the rs3213537 polymorphism was 244 
also was associated with increased proportion of fast-twitch muscle fibers in 287 Finnish 245 
individuals adjusted for sex and age (G/G (n = 189) 55.8 ± 14.9%, G/A (n = 91) 54.1 ± 246 
14.2%, A/A (n = 7) 43.1 ± 16.6%; P = 0.041). Based on these associations, the rs3213537 247 
polymorphism was selected for replication in the Russian and Brazilian cohorts. Given the 248 
low frequency of the homozygous genotype for the minor allele (i.e., the A/A genotype), the 249 
rs3213537 polymorphism was analyzed only under the dominant model (G/G vs. G/A+A/A). 250 
Of note, the transcript alleles instead of the genomic alleles were used to facilitate the link 251 
between this study and previous data (discovery stage) 10, that is, the G/A alleles represent the 252 
genomic C/T alleles. 253 
 Table 2 shows the genotype distribution and allele frequency of the rs3213537 254 
polymorphism in the three cohorts evaluated. Similar to that observed in the Japanese cohort, 255 
the G-allele was overrepresented in Russian sprinters compared to endurance athletes (86.4 256 
vs. 76.7%; P = 0.027) or controls (86.4 vs. 77.8%; P = 0.042). Indeed, the G/G genotype was 257 
overrepresented in Russian sprinters compared to endurance athletes (74.3 vs. 56.3%; P = 258 
0.017). In the Brazilian cohort, there was a difference of ≈ 5% of G/G genotype carriers 259 
between sprinters and the two other groups (controls and endurance athletes), but this 260 
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difference was not statistically significant. However, the direction of effect observed in the 261 
Brazilian cohort was the same as in the Japanese and Russian cohorts (OR > 1.2). 262 
 263 
Meta-analysis 264 
Meta-analysis showed that, in the pooled data of the Japanese, two Russian (including data 265 
from the previous study 10) and Brazilian cohorts, the G-allele frequency was significantly 266 
higher in sprinters compared with controls (P = 0.004), endurance athletes (P = 0.002) or 267 
controls + endurance athletes (P = 0.002), as shown in Table 3. Indeed, presence of the G/G 268 
genotype rather than G/A+A/A genotypes increased the chance of being a top-level sprinter 269 
compared to controls (OR: 1.49, 95% CI: 1.10–2.01; P = 0.005), endurance athletes (OR: 270 
1.79, 95% CI: 1.26–2.55; P = 0.001) or controls + endurance athletes (OR: 1.58, 95% CI: 271 
1.19–2.10; P = 0.002). There was no evidence of heterogeneity between studies. 272 
 273 
Sprint performance 274 
Figure 1 shows the comparison of the personal best times in 100-m performance between 275 
male sprinters with the G/G genotype (n = 26) and male sprinters with the G/A+A/A 276 
genotypes (n = 11). Male sprinters with the G/G genotype have been found to have 277 
significantly faster personal times (10.50 ± 0.26 s vs. 10.76 ± 0.31 s, P = 0.014). 278 
 279 
Discussion 280 
This study aimed to replicate potential sprint-related polymorphisms recently identified by a 281 
GWAS in three independent cohorts of top-level sprinters, as well as to evaluate their 282 
relationship with the proportion of fast-twitch muscle fibers. The main finding of this 283 
investigation involving 1,875 subjects was that the G-allele of the rs3213537 polymorphism 284 
was more frequent in sprinters and associated with increased proportion of fast-twitch muscle 285 
fibers in Japanese and Finnish individuals and the 100-m sprint performance in Brazilian and 286 
Russian sprinters, particularly the homozygotes (i.e., carriers of the G/G genotype). Meta-287 
analysis of 310 sprinters compared with 694 non-athletes and 381 endurance athletes showed 288 
that carriers of the G/G genotype were ≈ 1.6 times more likely to be a sprinter. 289 
 The rs3213537 is an intronic polymorphism found in the CPNE5 gene located at the 290 
6p21.2 region of the chromosome 6. Copines are a family of calcium-dependent, membrane-291 
binding proteins that are evolutionary conserved from protozoans to humans 15. Present in all 292 
major mammalian organs, copines may play fundamental roles in eukaryotic cell processes 16. 293 
Copine proteins contain two N-terminal C2 domains that involve residues important for 294 
calcium and phospholipid binding and a C-terminal A domain that may be involved in 295 
protein–protein interactions 15. This well characterized structure, especially the C2 domains, 296 
suggests their involvement in processes of signal transduction or membrane trafficking, which 297 
occurs in a calcium-dependent manner 16. However, their biological roles have not yet been 298 
fully defined. 299 
 There are at least eight different human copine proteins, which were referred to using 300 
roman numerals. Some of them (copine-I, -II and -III) are ubiquitously expressed, while the 301 
others have a more restricted expression profile 17. As an example, copine-VI is a cytosolic 302 
protein strongly expressed in hippocampal excitatory neurons that has been shown to affect 303 
the structural plasticity of the dendritic spine in response to presynaptic activity 18. Synaptic 304 
calcium signals lead to copine-VI translocation from the cytosol to the postsynaptic spine 305 
membranes, where they can serves as a calcium sensor that links neuronal activity to the 306 
subsequent long-term changes in synaptic structure by altering actin cytoskeleton morphology 307 
19. It was shown that copine-VI is responsible for the recruitment and local activation of the 308 
Rac family small GTPase 1 (Rac1) protein, which, in turn, activates the Rac1-PAK-LIMK1-309 
Cofilin pathway and cause actin re-arrangement in favor of the long-lasting, stable 310 
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strengthening of excitatory synapses 19. The molecular events underlying copine-V (encoded 311 
by CPNE5 gene) are less understood, however, there may be some resemblance to other 312 
copine proteins, such as copine-VI, as they are structurally highly similar. Nonetheless, they 313 
can be expressed in different brain regions or tissues and interact with different proteins. 314 
 Based on animal research, copine-V has been shown to play a key role in the 315 
development of the central nervous system as it is highly expressed during the embryonic 316 
brain development 20. Its expression decreases dramatically in the adult brain, remaining 317 
expressed in some non-neural tissues such as the heart, lung and muscles 21. Nevertheless, 318 
although its expression may be low in the cortex and almost undetectable in the cerebellum of 319 
the adult brain, CPNE5 is moderately expressed in the striatum of adult mice that have 320 
learned a complex motor task 22. Alterations in neuronal ensemble activity and synaptic 321 
plasticity of the striatum are highly relevant for efficient human motor actions because it is 322 
the foundation for long-term motor learning or motor memory 22, 23. 323 
 There is evidence supporting that a lack of motor memory may be detrimental to 324 
power and sprint performance 24. Individuals with superior working memory are able to 325 
perform faster and more accurate in motor tasks due to a better neural efficiency 25. Although 326 
with training, both neural activity and performance can be improved. Repetitive activation of 327 
the same neuronal circuit induces the clustering of new spines in postsynaptic membranes, 328 
favoring motor performance as it strengthens the dynamics of synaptic transmission 26. Thus, 329 
the most effective neural communication favors sprint performance. There are synaptic inputs 330 
at the central and peripheral levels, directly influencing the rapid activation of muscles 27. The 331 
ability of the neuromuscular system to increase contractile activity when muscle activation is 332 
intended to be performed as quickly as possible, referred to as Rate of Force Development 333 
(RFD), is considered vital for athletes requiring high-speed motor actions such as sprinters. 334 
Cross-sectional studies have shown that top-level sprint/power athletes are characterized by a 335 
markedly greater RFD 28. Moreover, athletes with a higher RFD demonstrated faster sprint 336 
times 29. Additional contributions may also occur due to differences in muscle fiber type 337 
composition—the RFD is faster in type II fibers 27.  338 
 Whether CPNE5 rs3213537 mutant carriers have impaired motor memory or muscle 339 
recruitment ability remains to be established, but the homozygous genotype for the major 340 
allele (i.e., the G/G genotype) was associated with fast-twitch muscle fibers and faster times 341 
in the 100-m event, which is considered the standard measure of the sprint ability of human 342 
bipedal locomotion 2. Based on its role in the central nervous system, CPNE5 polymorphisms 343 
were previously associated with alcohol dependence and obesity 20. In particular, the mutant 344 
allele of the CPNE5 rs3213537 polymorphism was strongly associated with alcohol abuse 20, 345 
which adversely impacts athletic performance in a number of different ways, including mood 346 
instability and sensory-motor system dysfunction 30.  347 
 As mentioned earlier, the CPNE5 rs3213537 is a gene variant occurring within an 348 
intron (genomic position and change: g.36748144C>T based on the Genome Reference 349 
Consortium Human Build 38). Introns harbour polymorphisms that can influence the 350 
expression of the genes that host them and modulate the genotype–phenotype relationship. 351 
Thus, this polymorphism may modulate CPNE5 expression and its calcium-modulated signal 352 
transduction. Interestingly, the interaction between copines and membranes occurs at 353 
concentrations of calcium that are likely to occur in the cytosol of stimulated cells but not in 354 
resting cells 16, and therefore, calcium-regulated phenotypes may be affected by mutations in 355 
the CPNE5 gene. Of particular interest, during neuromuscular junction formation, muscle 356 
fibers are intrinsically pre-specialized by clustering postsynaptic proteins, whereas the proper 357 
patterning of postsynaptic protein clusters in the center of developing muscle fibers and the 358 
subsequent innervation by the motor nerve critically depend on calcium signals 31. 359 
9 
 
Collectively, we speculate that the G/G genotype may be involved in synaptic plasticity and 360 
muscle fiber specificity in a way that favors sprint performance. 361 
 The present study has some limitations. Our muscle fiber composition study included 362 
only non-athlete individuals of a wide age range. However, if the polymorphism is associated 363 
with increased proportion of fast-twitch muscle fibers in untrained individuals, these 364 
individuals (carriers of the associated variant) are expected to respond better to sprint training. 365 
Power training, like that used by sprinters, seems to conserve the pre-training number of fast-366 
twitch fibers while increasing their fiber cross-sectional area, particularly type IIx fibers 32, 367 
favouring a higher RFD 33. Type IIx fibers have the highest muscle fiber conduction velocity 368 
34 and are considered key determinants of the RFD, especially in power-trained individuals 33. 369 
Power output in type IIx fibers was 2-fold higher than type IIa fibers and 14-fold greater than 370 
type I fibers 35. In line with this, the G-allele of the rs3213537 polymorphism was previously 371 
associated with the 10-m performance in a cohort of untrained Polish women 10, as well as 372 
associated with the 100-m performance in elite athletes. Although our case-control study 373 
included metabolically similar athletes, the performance association study evaluated only 374 
runners. Additional studies evaluating other sprint-oriented disciplines will be interesting, 375 
given that there may be differences between sports disciplines. 376 
 377 
Practical Applications 378 
The GWAS represents a promising and productive way to study sports-related phenotypes by 379 
providing a number of new candidate polymorphisms—that need to be evaluated in 380 
independent cohorts of different ethnicities and using different methodological approaches to 381 
better assess the relationship between the polymorphisms and traits of interest. In this regard, 382 
collaborative efforts involving well characterized athlete cohorts of different ethnic 383 
backgrounds will be of critical importance for further progress. In the present study, based on 384 
data from different cohorts, it is plausible to assume that the rs3213537 polymorphism (G/G 385 
genotype) may be part of a favorable genetic profile for sprinters. Notwithstanding, it is 386 
important to emphasize that sports phenotypes are complex and polygenic phenomena and 387 
should therefore be interpreted with caution.  388 
 389 
Conclusion 390 
The G/G genotype of the CPNE5 gene rs3213537 polymorphism was associated with sprint 391 
athletic status and performance. While the G-allele was associated with the proportion of fast-392 
twitch muscle fibers in Japanese and Finnish individuals, the G/G genotype was associated 393 
with faster personal times in the 100-m sprint performance among elite athletes from Brazil 394 
and Russia. It is worth mentioning that a complex network of genes contributes to sports 395 
performance, and the CPNE5 rs3213537 is just one of several variants that can make-up the 396 
genetic profile of the elite athlete. 397 
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Figure caption 509 
 510 
 511 
Figure 1 Association between the rs3213537 polymorphism and the best 100-m personal time 512 
in Brazilian and Russian male sprinters. The dashed line represents the qualifying time for the 513 
Tokyo 2020 Olympic Games (10.05 s). 514 
 515 
  516 
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Table 1 Description of the polymorphisms evaluated in the present study 517 
Polymorphism Location (position†) Consequence REF/ALT Sprint Allele Previous association 
rs3213537 Chromosome 6 (36748144) Intron variant G/A G (major allele) SFP, SPW, AS  
rs1929877 Chromosome 9 (78799771) Intergenic variant A/G G (minor allele) SFP, AS, MF 
rs17347590 Chromosome 20 (48525214) Intergenic variant C/A C (major allele) SFP, SPW, MF 
Legend: REF, Reference allele; ALT, Alternate allele; SFP, Associated with sprint performance in young 518 
British football players; SPW, Associated with sprint performance in healthy young Polish women; AS, 519 
Associated with sprint/power athlete status; MF, Associated with proportion of fast-twitch muscle fibers in 520 
Russian physically active subjects. †Genomic position based on GRCh38 (Genome Reference Consortium 521 
Human Build 38). 522 
  523 
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Table 2 Genotype distribution and allele frequency of the rs3213537 polymorphism in the 524 
Japanese, Russian and Brazilian cohorts 525 
  Genotypes (%)  Comparisons: P-value (Effect Direction) 
Group n G/G G/A A/A G allele G/G vs. G/A+A/A Alleles (G vs. A) 
Japanese sprint/power athletes 54 63.0 35.2 1.9 80.6 1.000 1.000 
Japanese endurance athletes 60 45.0 43.3 11.7 66.7 0.062 (OR: 2.08) 0.024 (OR: 2.07) 
Japanese controls 116 57.8 35.3 6.9 75.4 0.615 (OR: 1.24) 0.334 (OR: 1.35) 
        
Russian sprinters 70 74.3 24.3 1.4 86.4 1.000 1.000 
Russian endurance athletes 103 56.3 40.8 2.9 76.7 0.017 (OR: 2.24) 0.027 (OR: 1.93) 
Russian controls 117 62.4 30.8 6.8 77.8 0.110 (OR: 1.74) 0.042 (OR: 1.82) 
        
Brazilian sprinters 143 73.4 23.8 2.8 85.3 1.000 1.000 
Brazilian endurance athletes 162 68.5 28.4 3.1 82.7 0.378 (OR: 1.27) 0.439 (OR: 1.21) 
Brazilian controls 288 67.7 29.5 2.8 82.5 0.266 (OR: 1.32) 0.331 (OR: 1.23) 
Underlined values indicate an association trend (0.05 < P < 0.07), and double underlined values 526 




Table 3 Meta-analysis of the association between the rs3213537 polymorphism and sprinter athlete status 529 
Comparison Model OR (95% CI) Heterogeneity Test for overall effect 
Sprint/Power athletes vs. Controls G/G vs. G/A+A/A 1.49 (1.10–2.01) ² = 1.94 (P = 0.58); I² = 0% Z = 2.57 (P = 0.01) 
 Alleles (G vs. A) 1.47 (1.13–1.92) ² = 2.91 (P = 0.41); I² = 0% Z = 2.85 (P = 0.004) 
     
Sprint/Power athletes vs. Endurance athletes G/G vs. G/A+A/A 1.79 (1.26–2.55) ² = 3.30 (P = 0.35); I² = 9% Z = 3.25 (P = 0.001) 
 Alleles (G vs. A) 1.70 (1.22–2.35) ² = 3.70 (P = 0.30); I² = 19% Z = 3.16 (P = 0.002) 
     
Sprint/Power athletes vs. Controls + Endurance athletes G/G vs. G/A+A/A 1.58 (1.19–2.10) ² = 2.48 (P = 0.48); I² = 0% Z = 3.13 (P = 0.002) 
 Alleles (G vs. A) 1.55 (1.18–2.03) ² = 3.35 (P = 0.34); I² = 11% Z = 3.16 (P = 0.002) 
Comparisons are expressed as Odds Ratio (OR) and 95% Confidence Interval (95% CI). Heterogeneity between studies was assessed using the Cochran 530 
Q test (2) and the I2 statistic. 531 
 532 
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